Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 1.02
LTS:0QQD's Cash to Debt is ranked lower than
64% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. LTS:0QQD: 1.02 )
Ranked among companies with meaningful Cash to Debt only.
LTS:0QQD' s 10-Year Cash to Debt Range
Min: 0.05  Med: 0.85 Max: N/A
Current: 1.02
Equity to Asset 0.38
LTS:0QQD's Equity to Asset is ranked lower than
81% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. LTS:0QQD: 0.38 )
Ranked among companies with meaningful Equity to Asset only.
LTS:0QQD' s 10-Year Equity to Asset Range
Min: 0.03  Med: 0.68 Max: 0.84
Current: 0.38
0.03
0.84
Interest Coverage 0.88
LTS:0QQD's Interest Coverage is ranked lower than
98% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. LTS:0QQD: 0.88 )
Ranked among companies with meaningful Interest Coverage only.
LTS:0QQD' s 10-Year Interest Coverage Range
Min: 0.88  Med: 24.08 Max: 9999.99
Current: 0.88
0.88
9999.99
F-Score: 3
Z-Score: 3.00
WACC vs ROIC
11.12%
15.04%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 21.76
LTS:0QQD's Operating margin (%) is ranked higher than
92% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. LTS:0QQD: 21.76 )
Ranked among companies with meaningful Operating margin (%) only.
LTS:0QQD' s 10-Year Operating margin (%) Range
Min: 9.72  Med: 24.88 Max: 33.34
Current: 21.76
9.72
33.34
Net-margin (%) 14.54
LTS:0QQD's Net-margin (%) is ranked higher than
87% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.45 vs. LTS:0QQD: 14.54 )
Ranked among companies with meaningful Net-margin (%) only.
LTS:0QQD' s 10-Year Net-margin (%) Range
Min: 2.35  Med: 17.52 Max: 23.87
Current: 14.54
2.35
23.87
ROE (%) 12.95
LTS:0QQD's ROE (%) is ranked higher than
79% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. LTS:0QQD: 12.95 )
Ranked among companies with meaningful ROE (%) only.
LTS:0QQD' s 10-Year ROE (%) Range
Min: 1.81  Med: 15.10 Max: 115.87
Current: 12.95
1.81
115.87
ROA (%) 7.32
LTS:0QQD's ROA (%) is ranked higher than
76% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: -0.62 vs. LTS:0QQD: 7.32 )
Ranked among companies with meaningful ROA (%) only.
LTS:0QQD' s 10-Year ROA (%) Range
Min: 0.78  Med: 10.75 Max: 32.15
Current: 7.32
0.78
32.15
ROC (Joel Greenblatt) (%) 40.90
LTS:0QQD's ROC (Joel Greenblatt) (%) is ranked higher than
86% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. LTS:0QQD: 40.90 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
LTS:0QQD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 15.01  Med: 51.06 Max: 119.58
Current: 40.9
15.01
119.58
Revenue Growth (3Y)(%) -7.00
LTS:0QQD's Revenue Growth (3Y)(%) is ranked lower than
73% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. LTS:0QQD: -7.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
LTS:0QQD' s 10-Year Revenue Growth (3Y)(%) Range
Min: -7  Med: 10.55 Max: 25.6
Current: -7
-7
25.6
EBITDA Growth (3Y)(%) -13.30
LTS:0QQD's EBITDA Growth (3Y)(%) is ranked lower than
68% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. LTS:0QQD: -13.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
LTS:0QQD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -13.3  Med: 9.15 Max: 39.6
Current: -13.3
-13.3
39.6
EPS Growth (3Y)(%) -51.80
LTS:0QQD's EPS Growth (3Y)(%) is ranked lower than
94% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: -2.00 vs. LTS:0QQD: -51.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
LTS:0QQD' s 10-Year EPS Growth (3Y)(%) Range
Min: -51.8  Med: 11.55 Max: 41.7
Current: -51.8
-51.8
41.7
» LTS:0QQD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

Latest Guru Trades with LTS:0QQD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 29.00
0QQD's P/E(ttm) is ranked lower than
53% of the 155 Companies
in the Global Medical Devices industry.

( Industry Median: 28.20 vs. 0QQD: 29.00 )
Ranked among companies with meaningful P/E(ttm) only.
0QQD' s 10-Year P/E(ttm) Range
Min: 9.08  Med: 20.72 Max: 53.07
Current: 29
9.08
53.07
Forward P/E 14.77
0QQD's Forward P/E is ranked higher than
84% of the 97 Companies
in the Global Medical Devices industry.

( Industry Median: 22.68 vs. 0QQD: 14.77 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 29.00
0QQD's PE(NRI) is ranked lower than
52% of the 153 Companies
in the Global Medical Devices industry.

( Industry Median: 28.20 vs. 0QQD: 29.00 )
Ranked among companies with meaningful PE(NRI) only.
0QQD' s 10-Year PE(NRI) Range
Min: 9.07  Med: 20.73 Max: 53.03
Current: 29
9.07
53.03
P/B 2.94
0QQD's P/B is ranked higher than
55% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 3.23 vs. 0QQD: 2.94 )
Ranked among companies with meaningful P/B only.
0QQD' s 10-Year P/B Range
Min: 1.31  Med: 2.52 Max: 5.52
Current: 2.94
1.31
5.52
P/S 4.10
0QQD's P/S is ranked lower than
60% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.28 vs. 0QQD: 4.10 )
Ranked among companies with meaningful P/S only.
0QQD' s 10-Year P/S Range
Min: 1.82  Med: 3.49 Max: 7.26
Current: 4.1
1.82
7.26
PFCF 32.73
0QQD's PFCF is ranked lower than
52% of the 114 Companies
in the Global Medical Devices industry.

( Industry Median: 32.21 vs. 0QQD: 32.73 )
Ranked among companies with meaningful PFCF only.
0QQD' s 10-Year PFCF Range
Min: 9.54  Med: 21.05 Max: 36.62
Current: 32.73
9.54
36.62
POCF 20.39
0QQD's POCF is ranked higher than
56% of the 148 Companies
in the Global Medical Devices industry.

( Industry Median: 21.95 vs. 0QQD: 20.39 )
Ranked among companies with meaningful POCF only.
0QQD' s 10-Year POCF Range
Min: 6.88  Med: 13.87 Max: 26.18
Current: 20.39
6.88
26.18
EV-to-EBIT 19.91
0QQD's EV-to-EBIT is ranked higher than
58% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 22.01 vs. 0QQD: 19.91 )
Ranked among companies with meaningful EV-to-EBIT only.
0QQD' s 10-Year EV-to-EBIT Range
Min: 6.8  Med: 14.30 Max: 35.6
Current: 19.91
6.8
35.6
Shiller P/E 28.22
0QQD's Shiller P/E is ranked higher than
57% of the 95 Companies
in the Global Medical Devices industry.

( Industry Median: 31.07 vs. 0QQD: 28.22 )
Ranked among companies with meaningful Shiller P/E only.
0QQD' s 10-Year Shiller P/E Range
Min: 10.67  Med: 19.13 Max: 38.89
Current: 28.22
10.67
38.89
Current Ratio 13.11
0QQD's Current Ratio is ranked higher than
96% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.53 vs. 0QQD: 13.11 )
Ranked among companies with meaningful Current Ratio only.
0QQD' s 10-Year Current Ratio Range
Min: 1.14  Med: 2.94 Max: 13.11
Current: 13.11
1.14
13.11
Quick Ratio 11.78
0QQD's Quick Ratio is ranked higher than
96% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. 0QQD: 11.78 )
Ranked among companies with meaningful Quick Ratio only.
0QQD' s 10-Year Quick Ratio Range
Min: 0.71  Med: 1.87 Max: 11.78
Current: 11.78
0.71
11.78
Days Inventory 281.16
0QQD's Days Inventory is ranked lower than
80% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 129.39 vs. 0QQD: 281.16 )
Ranked among companies with meaningful Days Inventory only.
0QQD' s 10-Year Days Inventory Range
Min: 197.28  Med: 289.80 Max: 339.23
Current: 281.16
197.28
339.23
Days Sales Outstanding 68.33
0QQD's Days Sales Outstanding is ranked higher than
50% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 68.45 vs. 0QQD: 68.33 )
Ranked among companies with meaningful Days Sales Outstanding only.
0QQD' s 10-Year Days Sales Outstanding Range
Min: 56.27  Med: 65.37 Max: 93.39
Current: 68.33
56.27
93.39

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.80
0QQD's Dividend Yield is ranked lower than
74% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 1.43 vs. 0QQD: 0.80 )
Ranked among companies with meaningful Dividend Yield only.
0QQD' s 10-Year Dividend Yield Range
Min: 0.28  Med: 0.79 Max: 1.1
Current: 0.8
0.28
1.1
Dividend Payout 0.22
0QQD's Dividend Payout is ranked higher than
80% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 0.41 vs. 0QQD: 0.22 )
Ranked among companies with meaningful Dividend Payout only.
0QQD' s 10-Year Dividend Payout Range
Min: 0.15  Med: 0.21 Max: 0.24
Current: 0.22
0.15
0.24
Yield on cost (5-Year) 0.80
0QQD's Yield on cost (5-Year) is ranked lower than
72% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 1.37 vs. 0QQD: 0.80 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
0QQD' s 10-Year Yield on cost (5-Year) Range
Min: 0.28  Med: 0.79 Max: 1.1
Current: 0.8
0.28
1.1
Share Buyback Rate 100.00
0QQD's Share Buyback Rate is ranked higher than
99% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: -3.70 vs. 0QQD: 100.00 )
Ranked among companies with meaningful Share Buyback Rate only.
0QQD' s 10-Year Share Buyback Rate Range
Min: 100  Med: 3.60 Max: -8.4
Current: 100

Valuation & Return

vs
industry
vs
history
Earnings Yield (Greenblatt) (%) 5.00
0QQD's Earnings Yield (Greenblatt) (%) is ranked higher than
79% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. 0QQD: 5.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
0QQD' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 2.8  Med: 7.00 Max: 14.7
Current: 5
2.8
14.7
Forward Rate of Return (Yacktman) (%) 4.34
0QQD's Forward Rate of Return (Yacktman) (%) is ranked higher than
52% of the 98 Companies
in the Global Medical Devices industry.

( Industry Median: 4.08 vs. 0QQD: 4.34 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
0QQD' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 4.2  Med: 12.40 Max: 45.7
Current: 4.34
4.2
45.7

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:ZBH.USA, ZIM.Germany, ZBH.Switzerland,
Zimmer Holdings Inc was incorporated in 2001. The Company designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. It also provides other healthcare related services. Its products include orthopaedic reconstructive implants, spinal and trauma devices, biologics, dental implants and related surgical products. Its orthopaedic reconstructive devices restore function lost due to disease or trauma in joints such as knees, hips, shoulders and elbows. Its dental reconstructive implants restore function and aesthetics in patients who have lost teeth due to trauma or disease. Its spinal devices are utilized by orthopaedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities and trauma in all regions of the spine. Its trauma products are devices used to reattach or stabilize damaged bone and tissue to support the body's natural healing process. The Company has its operations in more than 25 countries and markets its products in more than 100 countries. The Company operates in a single industry but have three reportable geographic segments, the Americas, Europe and Asia Pacific. The Americas, which is comprised of the U.S. and includes other North, Central and South American markets; Europe, which is comprised of Europe and includes the Middle East and African markets; and Asia Pacific, which is comprised of Japan and includes other Asian and Pacific markets. The Company's customers include orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. It markets and sells its products through three channels; direct to healthcare institutions, such as hospitals, referred to as direct channel accounts; through stocking distributors and healthcare dealers; and directly to dental practices and dental laboratories. The Company operates distribution facilities domestically in Warsaw, Indiana; Southaven, Mississippi; and Carlsbad, California and internationally in Australia, Austria, Belgium, Canada, the Czech Republic, China, Finland, France, Germany, Hong Kong, India, Italy, Japan, Korea, Malaysia, the Netherlands, New Zealand, Portugal, Russia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand and the United Kingdom. The Company competes with the DePuy Synthes Companies of Johnson & Johnson, Stryker Corporation, Biomet, Inc., and Smith & Nephew plc. It protects its proprietary rights through a variety of methods, including confidentiality agreements and proprietary information agreements with vendors, employees, consultants and others who may have access to proprietary information. The Company is subject to government regulation in the countries in which it conducts business.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK